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Abstract: The forefront of the anti-viral defence is sometimes aimed at virion attachment to a host membrane. This
step or, more specifically, virion contacts with cellular membrane receptors (or, e.g., glycolipids) can be
inhibited by antibodies (or specially chosen or designed compounds) via their association with virions.
In this case, the full-scale attachment of virions to a host membrane occurs via a subtle interplay of the
formation and rupture of multiple virion-inhibitor and virion-receptor bonds. We present a kinetic model
describing this interplay and illustrating general trends in the process under consideration.
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1. Introduction
Viruses contain a DNA or RNA genome protected by aprotein capsid and sometimes also by a lipid membraneenvelope. Their replication cycles include virion attach-ment to a host-cell lipid membrane, penetration, uncoatingand release of genome, genome replication, viral proteinsynthesis, capsid assembly, and escape from the host [1, 2].Every step of this pathway can be targeted for the anti-viral host defence. In particular, the forefront of the de-fence is sometimes aimed at virion attachment to and pen-etration of a host membrane [3–5]. These steps can be
∗E-mail: zhdanov@catalysis.ru
inhibited by antibodies (or specially chosen or designedcompounds [6, 7]) via their association with virions with noparticipation of any other components of the immune sys-tem. The interpretation of the corresponding experimentshas long been focused on the number of antibodies neededto neutralize a virion [3, 8, 9]. The available kinetic mod-els of the first steps of the virion-membrane interactiondescribe the interplay between virion diffusion and bind-ing to cellular receptors [10, 11], fusion and endocytosisof membrane-enveloped virions [12, 13], and virion detach-ment from a membrane [14, 15]. Models treating in detailthe effect of inhibitors on virion attachment to a membraneare still lacking. In this Communication, we introduce andanalyze the first model of this category. It scrutinizes therole of various factors in this inhibition and is expectedto be useful for researches interested in the correspond-
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ing biophysics and/or biotechnological applications. Themodel is applicable to the situations occurring in vivo andalso to those realized in academic studies (e.g., with at-tached cells or supported lipid bilayers). In the lattercase, comparison of the predictions of the model with thefeatures of experimentally measured kinetics may help toclarify details of the mechanism(s) of the inhibition.
2. Model
If a virion has no envelope, its attachment to a lipid mem-brane usually occurs via the formation of multiple rela-tively weak bonds between the binding sites at a proteincapsid and cellular receptors or, e.g., glycolipids (to bespecific, we refer below to cellular receptors). Membrane-enveloped virions usually have protein spikes in order tocontact a host membrane. An antibody or a specially cho-sen compound (further referred to as an inhibitor) can bindto the binding sites at the virion surface (i.e., to the sitesat a protein capsid or to the protein spikes) and suppressthe attachment of virions. The suppression is efficient ifthe majority of binding sites are blocked. The associationof an inhibitor with binding sites is, however, usually re-versible, so there is a probability that some of the sitesare not blocked. In such cases, a virion can still bind to amembrane via one or two weak bonds. Whether such bind-ing results in the full-scale attachment of a virion dependson the competition between rupture of the virion-inhibitorbonds, and formation and rupture of new virion-membranebonds. Our goal is to describe the interplay of these pro-cesses.In our model, the distance between the binding sites isconsidered to be larger than the inhibitor and receptorsizes, and accordingly the cooperative effects in the bind-ing are neglected. In solution (far from the membrane), theinhibitor attachment to and detachment from the bindingsites are assumed to be at equilibrium, and accordinglythe probability of occupation of a binding site by an in-hibitor molecule is described by the conventional equa-tion, ρ = κacκd + κac , (1)
where κa, κd and c are the inhibitor attachment and de-tachment rate constants and concentration, respectively.
If a virion has no envelope, its protein capsid can beviewed as a biological nanoparticle (see, e.g., Fig. 3 be-low). The interaction or, more specifically, the initial in-teraction of a virion with a membrane (before appreciablepenetration) includes a few binding sites located at oneof its facets, and may also include a few sites located at
adjacent facets. The initial interaction of a membrane-enveloped virion with a membrane includes a few bindingsites as well. Focusing on this stage, we consider that thevirion binding to the membrane is mediated by n equiva-lent binding sites located in the virion-membrane contactarea.The attachment of virions to the membrane is consideredto be kinetically limited (the diffusion-related correctionscan be taken into account if necessary by using the con-ventional theory of diffusion-limited reactions). In particu-lar, the attachment is considered to be possible if at leastone of the n binding sites is vacant. The attachment rateconstant is represented as
ka = k◦ n−1∑i=0 piχiηi, (2)
where k◦ is the rate constant of the formation of the firstvirion-receptor bond in the case when all the n bindingsites are vacant, i is the number of inhibitors occupying thesites in the beginning (at t = 0) of the virion-membranecontact, pi = n!ρi(1− ρ)n−ii! (n− i)! (3)is the probability that i binding sites are occupied by theinhibitor at the beginning of the virion-membrane interac-tion, χi = (n− i)/n (4)
is the factor taking into account that only n − i vacantsites are available for the formation of the first virion-receptor bond in the beginning, and ηi is the probabilitythat the formation of the first virion-receptor bond resultseventually in the full-scale attachment of a virion.If ηi = 1, i.e., the formation of the first virion-receptor bondis sufficient for the full-scale attachment of a virion, Eq. 2in combination with Eqs. 3 and 4 yield
ka = k◦(1− ρ). (5)
Using expression 1 for ρ, one can rewrite Eq. 5 as
ka = k◦κdκd + κac . (6)
In reality, the formation of the first virion-receptor bondis often not sufficient for the full-scale attachment of avirion (especially if ρ is close to unity), and we shouldtake into account that ηi < 1. To calculate ηi, we useprobabilities Pl,j (t) (0 ≤ l + j ≤ n) that at time t afterthe beginning of the virion-membrane contact, the contact
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area contains l and j binding sites occupied by the in-hibitor molecules and membrane receptors, respectively.The equations, used here for these probabilities, are sim-ilar to those employed earlier to describe cell adhesion(reviewed in Ref. [16]) and virion detachment (see the sup-plementary material in Ref. [15]). The only difference isthat the latter processes are usually described assumingall the bonds (e.g., the capsid-glycolipid bonds [15]) tobe equivalent, while we scrutinize formation of the bondsof two types including the capsid-inhibitor bonds and thecapsid-receptor bonds. Although the approach we em-ploy is conceptually simple, the corresponding equationsare cumbersome. To simplify the analysis, we take intoaccount that during the virion-membrane contact the for-mation of new bonds with receptors is often much moreprobable than the formation of new bonds with the in-hibitor (this is the case provided that the concentration,C , of receptors is not too low). Under this condition, weneglect the formation of new bonds with the inhibitor. Inthis case, the type of the equations we should solve is asfollows
dPl,j /dt = (l+ 1)κdPl+1,j − lκdPl,j+(j + 1)υrPl,j+1 − jυrPl,j+(n− l− j + 1)υfCPl,j−1 − (n− l− j)υfCPl,j ,(7)where υf and υr are the rate constants of the formationand rupture of the virion-receptor bonds. Using the equa-tions of this type, we neglect lateral receptor-receptor in-teraction resulting in correlations in the arrangement ofreceptors (depending on the value of this interaction andreceptor concentration, such correlations may be observedon the length scale from a few nm to µn). In other words,we neglect the formation of domains (or rafts) in a mem-brane (this effect is reviewed in Refs. [17, 18]). This ap-proximation is often reasonable, at least in the case whenC is not too high. If necessary, the raft formation canbe taken into account analytically (e.g., by employing thequasi-chemical approximation as described in Ref. [15]) orby using the Monte Carlo technique.In addition, we consider that the formation of new bondswith receptors is fast compared to the rupture of bonds,i.e., υfC  υf (and υfC  κd). In this case, the relaxationin the space of the virion-receptor bonds is rapid, andaccordingly we consider that these bonds are at the equi-librium corresponding to a given number (l) of the virion-inhibitor bonds. Under this condition, we can introducethe virion detachment rate constant, rl, corresponding tonumber l, and replace Eqs. 7 by the reduced equationsdescribing the rupture of the virion-inhibitor bonds andthe virion detachment. Following this way, we introducethe probability, Pl(t), that at time t after the beginning ofthe virion-membrane contact, the contact area contains l
binding sites occupied by the inhibitor. If i (0 ≤ i ≤ n−1)is the initial number of inhibitors in this area, we have i+1probabilities Pl(t) with 0 ≤ l ≤ i. The equations for theseprobabilities with l = i, 1 ≤ l ≤ i − 1 and l = 0 are,respectively, read as
dPi/dt = −iκdPi − riPi, (8)
dPl/dt = (l+ 1)κdPl+1 − lκdPl − rlPl, (9)
dP0/dt = κdP1. (10)
Using these equations, we allow the virion detachmentfor 1 ≤ l ≤ i and neglect for l = 0. Physically, this isreasonable if, in the absence of the inhibitor, the virionbinding is strong and the virion detachment in this case iseither slow, on the time scale of attachment, or becomesimpossible due to subsequent steps on the pathway of thevirion-membrane interaction.Integrating Eqs. 8-10 with the corresponding initial con-ditions,
Pl(0) = { 1 for l = i,0 for 0 ≤ l ≤ i− 1, (11)
we obtain ∫ ∞
0 Pi(t)dt = 1iκd + ri , (12)∫ ∞
0 Pl(t)dt = (l+ 1)κdlκd + rl
∫ ∞
0 Pl+1(t)dt, (13)
P0(∞) = κd ∫ ∞0 P1(t)dt. (14)The probability that the formation of the first virion-receptor bond results in the full-scale attachment of avirion can be identified with P0(∞), i.e, ηi ≡ P0(∞). Em-ploying this definition and Eqs. 11-14, we get
ηi = i∏l=1 pl, (15)
where pl = lκdlκd + rl . (16)The physical meaning of these expressions is straightfor-ward. In each state l (with l > 0), a virion may eitherreach state l− 1 or leave the membrane. The probabilityof a transition to state l− 1 is given by expression 16. Toreach the fully bound state (with l = 0) from the initialstate (with l = i), a virion should sequentially perform aseries of such transitions down to l = 0, and accordinglythe probability to reach the fully bound state is equal toa product of the corresponding probabilities pl (Eq. 15).
1212
Vladimir P. Zhdanov
0 1 2 3 4 5
-6
-5
-4
-3
-2
-1
0
(a)
0.9
0.8
ρ = 0.7
 
 
Lo
g 1
0( 
p i
 )
i
0 1 2 3 4 5
-6
-5
-4
-3
-2
-1(b)
0.9
0.8
ρ = 0.7
 
 
Lo
g 1
0( 
p i
 χ i 
)
i
0 1 2 3 4 5
-2
-1
0
(c)
 
 
Lo
g 1
0( 
η i )
i
0 1 2 3 4 5
-6
-5
-4
-3
-2
-1(d)
0.9
0.8
ρ = 0.7
 
 
Lo
g 1
0( 
p i
 χ i 
η i )
i
Figure 1. Specification of the contribution of various factors to the normalized attachment rate constant, ka/k◦. This rate constant is determined
by a sum of products piχiηi (Eq. 2). Panels (a-c) show probabilities pi (Eq. 3), piχi (Eqs. 3 and 4), and ηi (Eq. 15) as a function of i.
Panel (d) exhibits the dependence of the whole products of these factors on i. The results presented in panels (a-d) have been obtained
assuming that the number of binding sites located in the virion-membrane contact area is equal to 6.
If the number of the virion-inhibitor bonds is l, the viriondetachment rate constant can be represented as (seeEq. 16 in the main text or Eq. 8 in the supplementarymaterial in Ref. [15])
rl = r∗(1 + κfC/κr)n−l , (17)
where r∗ is the departure rate constant corresponding tothe state with no virion-receptor bonds. Employing ex-pression 17, we neglect correlations in the arrangementof receptors. As already noticed below Eq. 7, this approx-imation is often reasonable at least in the case when theconcentration of receptors in a membrane is not too highand, if necessary, it can be relaxed.Eqs. 2-4, and 15-17 allow us to calculate the impact ofvarious parameters on the full-scale virion attachmentprobability, ka/k◦.
3. Model predictions
Typical predictions of our model are exhibited in Figs. 1and 2. In particular, taking into account that accordingto Eq. 2 the normalized attachment rate constant, ka/k◦,is determined by a sum of products piχiηi correspondingto different numbers of inhibitors occupying the sites inthe beginning of the virion-membrane contact, we show inFig. 1(a-c) the dependence of pi, piχi, and ηi on i for n = 6(an example of a virion with this n is presented in Fig. 3),ρ = 0.7, 0.8, and 0.9, κfC/κr = 10, and κd/r∗ = 10−3.The dependence of the whole products of these factors oni is exhibited in Fig. 1(d). In this case, ρ is appreciableand initially a virion typically has in the contact area 4or 5 binding sites occupied by the inhibitor (Fig. 1(a)).The states with i = 3-5, makes the main contribution tothe initial contact (Fig. 1(b)). The probability that theformation of the first virion-receptor bond results in thefull-scale attachment of a virion is close to unity for 0 ≤i ≤ 3, and appreciably smaller than unity for i = 4 andespecially for i = 5 (Fig. 1(c)). Due to the interplay ofthese factors, the main contribution to the rate constant ofthe full-scale virion attachment to the membrane is given
1213
Inhibition of the receptor-mediated virion attachment to a lipid membrane
-2 -1 0 1 2
0.0
0.2
0.4
0.6
0.8
1.0
 
 
k a
 / 
k o
 
Log10( κac /κd )
Figure 2. Probability of the full-scale virion attachment as a function
of κac/κd according to Eq. 2 with ηi < 1 (solid line) and
Eq. 6 with ηi = 1 (dashed line).
 
Figure 3. Frontal view of a capsid of norovirus including 45 dimers
of the capsid protein (adapted from Ref. [15]). These pro-
teins form facets. The six binding sites on the vertices of
a hexagonal facet (this facet can be viewed as a contact
area) are indicated by light green circles (these sites, lo-
cated ∼ 6 nm apart, are linked by a black line) along with
the neighboring binding sites on the same dimers. The
latter sites are located ∼2 nm downwards with respect to
the hexagonal facet formed by the former sites. Attach-
ment of this virus to a membrane can be inhibited, e.g., by
citrate [6] and other compounds [7].
by the state with i = 3 (Fig. 1(d)).Physically, the normalized attachment rate constant,ka/k◦, represents the probability of the full-scale virionattachment. This probability decreases with increasingκac/κd (Fig. 2). The decrease of ka/k◦, predicted by Eq. 2(with ηi < 1), is seen to be somewhat more abrupt com-pared to that predicted by Eq. 6 (with ηi = 1).
4. Conclusion
Although the results presented in Figs. 1 and 2 have beenobtained for specific values of the model parameters, theyillustrate general trends in the inhibition of the virion at-tachment to a lipid membrane. The simplest situationtakes place when the formation of the first virion-receptorbond is sufficient for the full-scale attachment of a virion.In this case (with ηi = 1), the dependence of the attach-ment rate constant on c is described by a simple expres-sion 6 of the Langmuirian type [19] (in biophysics, such ex-pressions are widely used to describe the ligand-receptorinteraction or the function of transcription factors [20]). Ifηi < 1, i.e., the virion attachment may be followed bydetachment, the dependence of the attachment rate con-stant on c is expected (Fig. 2) to be stronger comparedto that predicted by expression 6. To verify these predic-tions, one needs to perform accurate measurements of thedependence of this rate constant on c. At present, suchmeasurements are lacking.Finally, we mention possible extensions of the theory pre-sented here. As it stands, the model does not take dif-fusion limitations into account. Such limitations may beimportant. Their analysis depends on specific geometryand if necessary can be performed by using the conven-tional theory of diffusion-limited reactions (see, e.g., gen-eral theory [21], recent related articles [10, 11, 22, 23],and references therein). Among other extensions of ouranalysis, we may refer to the case of attachment of an in-hibitor to two binding sites. More complex rules describ-ing the interplay between the formation of capsid-inhibitorand capsid-receptor bonds can also be introduced into themodel.
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